
BREAKING NEWS: FDA APPROVES INNOVATIVE NASAL SPRAY FOR DEPRESSION
The U.S. Food and Drug Administration (FDA) has approved Spravato (esketamine) CIII, a revolutionary nasal spray designed to help individuals battling treatment-resistant depression (TRD). ... Read More



